PHAT - Phathom Pharmaceuticals, Inc.
IEX Last Trade
6.62
0.200 3.021%
Share volume: 1,191,003
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.28%
PREVIOUS CLOSE
CHG
CHG%
$6.42
-0.32
-0.05%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-06-14 | 2023-08-10 | 2023-11-09 | 2024-11-07 | 2024-06-14 | 2024-08-08 | 2024-11-07 | |
| Cash flow financing | 14.072 M | 141.502 M | 13.000 K | 211.993 M | 9.900 M | 24.771 M | 122.057 M | |
| Other financing cash flows | 0.000 | 0.000 | 13.000 K | 172.675 M | 0.000 | 0.000 | 282.000 K | |
| Cash flow | -25.811 M | 119.296 M | -32.840 M | 167.721 M | -59.160 M | -45.996 M | 58.440 M | |
| Net income | -37.814 M | -40.965 M | -43.243 M | -79.570 M | -82.852 M | -91.446 M | -85.577 M | |
| Depreciation | 146.000 K | 123.000 K | 121.000 K | 185.000 K | 214.000 K | 197.000 K | 191.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 416.000 K | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -214.000 K | -6.000 K | -939.000 K | -475.000 K | -40.000 K | -46.000 K | -44.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 214.000 K | 6.000 K | 939.000 K | 475.000 K | 40.000 K | 46.000 K | 44.000 K | |
| Cash Change | -25.811 M | 119.296 M | -32.840 M | 167.721 M | -59.160 M | -45.996 M | 58.440 M |